Gait Assessment Via Telephone Application
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 27, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Gait Assessment Via Telephone Application" is studying a new smartphone app called Gait-Analyzer, which aims to assess walking patterns. Researchers want to compare this app's effectiveness to the traditional high-tech method of computerized gait analysis, which is usually very accurate but also expensive and not easily available. By looking at how well the app measures walking parameters, the study hopes to determine if it can be a reliable alternative for assessing gait in everyday settings.
To participate in this study, individuals should be between 18 and 26 years old and have a normal body weight. However, those with certain conditions, such as leg injuries or specific foot problems, or who have had recent surgeries, won’t be eligible. Participants can expect to use the Gait-Analyzer app to record their walking patterns, helping researchers gather important information that could make gait analysis more accessible for everyone. This trial is currently recruiting participants of all genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 26 years.
- • Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2)
- Exclusion Criteria:
- • Presence of lower extremity rotational problems (such as high femoral anteversion, internal tibial torsion, metatarsus adductus).
- • History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months.
- • History of lower extremity injury within the last 6 months.
- • Leg length discrepancy.
- • Presence of third-degree pes planus.
- • Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases.
- • History of pain, deformity, or surgery related to the vertebral column and upper extremities.
- • Presence of cognitive, mental, and/or severe psychiatric disorders
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Ayşenur Erekdağ, MSc
Principal Investigator
Bezmialem Vakif University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported